Literature DB >> 16971175

Real-time PCR for mumps diagnosis on clinical specimens--comparison with results of conventional methods of virus detection and nested PCR.

Claudia H Krause1, Kirstine Eastick, Marie M Ogilvie.   

Abstract

BACKGROUND: Since November 2003, the UK has seen a dramatic rise in the number of mumps cases, resulting in increasing demands on virology laboratories to confirm mumps infection in a timely and efficient manner. Traditional mumps virus detection methods are often insensitive, lengthy, and cumbersome. Some laboratories in the UK now use molecular methods that are based on nested polymerase chain reaction (PCR). Early serological diagnosis often relies on detection of anti-mumps IgM, which may be absent in the first 10 days of illness.
OBJECTIVES: We compared a one-step real-time RT-PCR with an established nested PCR (SH-PCR) and virus detection by culture and antigen detection, and assessed the clinical usefulness of mumps real-time PCR for diagnosis from CSF. STUDY
DESIGN: In total, 280 clinical samples were investigated by real-time PCR, nested PCR and a combination of traditional virus detection methods (antigen detection on oral samples, cell culture on all samples). Furthermore, 88 CSF samples submitted for diagnosis of possible viral meningitis were analysed by real-time PCR.
RESULTS: The real-time PCR detected the highest number of positive oral samples (119/180) compared to SH-PCR (92/180) and combined virus culture and antigen detection procedures (90/180). Sensitivity of mumps virus detection in urine was poor for all three methods: 34.0% (traditional detection), 29.8% (real-time PCR) and 2.1% (SH-PCR), respectively. Real-time PCR on 88 CSF samples identified five patients with mumps meningitis, significantly increasing viral diagnosis in this cohort.
CONCLUSION: Real-time PCR on oral samples is the investigation of choice for mumps infection. Mumps virus detection in urine by any of the PCRs used was clearly less successful. Real-time PCR on CSF samples seems a promising adjunct for diagnosis of mumps meningitis, especially in an age group with high incidence of mumps.

Entities:  

Mesh:

Year:  2006        PMID: 16971175     DOI: 10.1016/j.jcv.2006.07.009

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  12 in total

1.  Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage.

Authors:  Rebecca H Bitsko; Margaret M Cortese; Gustavo H Dayan; Paul A Rota; Luis Lowe; Susan C Iversen; William J Bellini
Journal:  J Clin Microbiol       Date:  2008-01-09       Impact factor: 5.948

2.  Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform.

Authors:  Jason J Leblanc; Janice Pettipas; Ross J Davidson; Graham A Tipples; Joanne Hiebert; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

3.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

4.  Laboratory diagnosis of mumps in a partially immunized population: The Nova Scotia experience.

Authors:  Tf Hatchette; R Davidson; S Clay; J Pettipas; J Leblanc; S Sarwal; M Smieja; Kr Forward
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland.

Authors:  Michael J Carr; Eibhlín Moss; Allison Waters; Jonathan Dean; Li Jin; Suzie Coughlan; Jeff Connell; William W Hall; Jaythoon Hassan
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

6.  Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.

Authors:  Irene Barrabeig; Josep Costa; Ariadna Rovira; M Angeles Marcos; Ricard Isanta; Rubén López-Adalid; Ana Cervilla; Nuria Torner; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens.

Authors:  Jennifer D Boddicker; Paul A Rota; Trisha Kreman; Andrea Wangeman; Louis Lowe; Kimberly B Hummel; Robert Thompson; William J Bellini; Michael Pentella; Lucy E Desjardin
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

8.  A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-07-10       Impact factor: 9.079

9.  Excretion of transmissible spongiform encephalopathy infectivity in urine.

Authors:  Luisa Gregori; Gabor G Kovacs; Irina Alexeeva; Herbert Budka; Robert G Rohwer
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

10.  Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

Authors:  Arnaud G L'Huillier; Alireza Eshaghi; C Sarai Racey; Katherene Ogbulafor; Ernesto Lombos; Rachel R Higgins; David C Alexander; Erik Kristjanson; Jocelyn Maregmen; Jonathan B Gubbay; Tony Mazzulli
Journal:  Virol J       Date:  2018-06-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.